Company · CIK 1966522
BioLingus (Cayman) Ltd
| CIK | 1966522 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | E9 |
| Business address | Switzerland |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | none on EDGAR |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-273093 | 2023-06-30 | 2024-01-31 | 7 |
Filings
8| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-01-31 | EFFECTDeclared effective | 333-273093 | 9999999995-24-000258 |
| 2023-12-19 | F-1/AAmendment | 333-273093 | 0001493152-23-045393 |
| 2023-12-13 | F-1/AAmendment | 333-273093 | 0001493152-23-044684 |
| 2023-11-09 | F-1/AAmendment | 333-273093 | 0001493152-23-040135 |
| 2023-07-27 | F-1/AAmendment | 333-273093 | 0001493152-23-025645 |
| 2023-07-13 | F-1/AAmendment | 333-273093 | 0001493152-23-024425 |
| 2023-06-30 | F-1Registration filed | 333-273093 | 0001493152-23-023168 |
| 2023-03-29 | DRSDraft made public | 377-06656 | 0001493152-23-009413 |